Phase 4
Completed N=86
TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery
Colorectal Surgery · TAP Blocks
Source: ClinicalTrials.gov NCT03080142 ↗
Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Mean Opioid Consumption in Morphine Opioid Equivalents in mg — 112.12; 97.95 IV morphine equivalents (mg)
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This is a prospective randomized study designed to compare the pain control from a single shot of liposomal bupivacaine (Exparel) against transversus abominus plane (TAP) catheters with ropivicaine bolus in patients undergoing elective colorectal surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Opioid Consumption in Morphine Opioid Equivalents in mg |
112.12; 97.95 | — |
Eligibility Criteria
Inclusion Criteria
- Patients scheduled for elective colorectal surgery with Dr. Linda Farkas
Exclusion Criteria
- Patients under 18 years of age
- Patient over 90 years of age
- Pregnancy
- Prisoners
- Patients unable to provide consent
- Patients on systemic anticoagulation therapy
- Patients with an allergy to local anesthetics
Data sourced from ClinicalTrials.gov (NCT03080142). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.